Ticker LaunchReverse merger · Completed · GRI
GRI Bio Operations, Inc.
Reverse merger with Vallon Pharmaceuticals, Inc. (VLON)
GRI Bio Operations, Inc. merged into Vallon Pharmaceuticals, Inc. (VLON), a clinical-stage biopharma developing abuse-deterrent CNS drugs, in a reverse merger that takes the private company public. The agreement was signed and the deal closed on the same day, Apr 21, 2023. The combined company trades as GRI Bio, Inc. (GRI) on Nasdaq.
GRI Bio, Inc. is a clinical-stage biotechnology company developing natural killer T cell modulators for inflammatory, fibrotic and autoimmune diseases, with a library of more than 500 proprietary compounds.
- Status
- Completed
- Private company
- GRI Bio Operations, Inc.
- Public company
- Vallon Pharmaceuticals, Inc. (VLON)
- Public company business before
- clinical-stage biopharma developing abuse-deterrent CNS drugs
- Announced
- Signed and closed the same day
- Closed
- Apr 21, 2023
- Combined company
- GRI Bio, Inc. (GRI)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Apr 21, 2023
- Closing exhibit
- Announcement 8-K May 13, 2022
- Announcement exhibit
- All filings on EDGAR CIK 1824293
Other completed reverse mergers
- Prairie Operating Co., LLCinto Creek Road Miners, Inc. · May 3, 2023
- CardioVentures, Inc.into AVRA Medical Robotics, Inc. · Apr 14, 2023
- Zircon Corporationinto Harmony Energy Technologies Corporation · Apr 13, 2023
- Charging Robotics Ltd.into Fuel Doctor Holdings, Inc. · Apr 7, 2023
- Megamile Capital, Inc. (Mag Mile Capital)into Myson, Inc. · Mar 30, 2023
- Sannong Youxuan (BVI) Limitedinto Huaizhong Health Group, Inc. · Mar 27, 2023